{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:57:46Z","timestamp":1762145866881,"version":"3.41.2"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>There is growing interest in the comorbidity of vascular and neurodegenerative pathologies in patients with cerebrovascular disease (CVD) beyond cerebral amyloid angiopathy (CAA). However, the relationship between amyloid-\u03b2 and vascular cognitive impairment (VCI) remains debated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To investigate the association between VCI and amyloid-\u03b2 deposition in non-CAA CVD patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>PubMed, Embase, Web of Science, PsycINFO and CENTRAL databases were systematically searched. Observational studies, including case\u2013control and cohort studies, associating cognitive scores with amyloid load measured by positron emission tomography were selected. Meta-analyses were performed to assess the strength of amyloid\u2013cognition associations across CVD subtypes and cognitive domains. A random-effects model using the inverse variance method was used, with heterogeneity evaluated by Q-statistics and I2 statistics. Meta-regression analyses were conducted to examine the influence of moderators, and publication bias was assessed using funnel plots and Egger\u2019s test. All statistical analyses were performed using StataMP 18.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Twenty-seven eligible studies encompassing 2894 participants were included. Among non-CAA CVD patients, global cognitive performance was significantly lower in those with higher amyloid-\u03b2 deposition (standardized mean difference\u2009=\u2009\u22120.43, P &amp;lt; 0.001). The correlation strength varied across cognitive domains (executive function: r\u2009=\u2009\u22120.41; language: r\u2009=\u2009\u22120.36; memory: r\u2009=\u2009\u22120.29; all P &amp;lt; 0.001). The correlation was significant in patients with subcortical vascular disease (r\u2009=\u2009\u22120.43, P &amp;lt; 0.001) but not post-stroke patients (r\u2009=\u2009\u22120.19, P &amp;gt;\u20090.05).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Amyloid-\u03b2 load is associated with cognitive decline in non-CAA CVD patients. This is more pronounced in patients with subcortical vascular disease than in post-stroke patients. Executive function is the most susceptible domain in VCI when the level of amyloid-\u03b2 increases.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ageing\/afae240","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T06:05:21Z","timestamp":1730181921000},"source":"Crossref","is-referenced-by-count":2,"title":["Associations between amyloid-<b>\u03b2<\/b> load and cognition in cerebrovascular disease beyond cerebral amyloid angiopathy: a systematic review and meta-analysis of positron emission tomography studies"],"prefix":"10.1093","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1397-5224","authenticated-orcid":false,"given":"Jie","family":"Zhang","sequence":"first","affiliation":[{"name":"Center for Rehabilitation Medicine , Rehabilitation & Sports Medicine Research Institute of Zhejiang Province, Department of Rehabilitation Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, 158 Shangtang Road, Hangzhou 310014,","place":["China"]},{"name":"Wellcome Center for Human Neuroimaging , Department of Imaging Neuroscience, Institute of Neurology, , 12 Queen Square, London WC1N 3AR,","place":["United Kingdom"]},{"name":"University College London , Department of Imaging Neuroscience, Institute of Neurology, , 12 Queen Square, London WC1N 3AR,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathy J","family":"Price","sequence":"additional","affiliation":[{"name":"Wellcome Center for Human Neuroimaging , Department of Imaging Neuroscience, Institute of Neurology, , 12 Queen Square, London WC1N 3AR,","place":["United Kingdom"]},{"name":"University College London , Department of Imaging Neuroscience, Institute of Neurology, , 12 Queen Square, London WC1N 3AR,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Zhao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Brain and Cognitive Science , Institute of Psychology, , 16 Lincui Road, Beijing 100101,","place":["China"]},{"name":"Chinese Academy of Sciences , Institute of Psychology, , 16 Lincui Road, Beijing 100101,","place":["China"]},{"name":"Institute of Cognitive Neuroscience, University College London , Alexandra House, 17 Queen Square, London WC1N 3AZ,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Tang","sequence":"additional","affiliation":[{"name":"Center for Rehabilitation Medicine , Rehabilitation & Sports Medicine Research Institute of Zhejiang Province, Department of Rehabilitation Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, 158 Shangtang Road, Hangzhou 310014,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuchang","family":"Zhong","sequence":"additional","affiliation":[{"name":"Center for Rehabilitation Medicine , Rehabilitation & Sports Medicine Research Institute of Zhejiang Province, Department of Rehabilitation Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, 158 Shangtang Road, Hangzhou 310014,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Lou","sequence":"additional","affiliation":[{"name":"Center for Rehabilitation Medicine , Rehabilitation & Sports Medicine Research Institute of Zhejiang Province, Department of Rehabilitation Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, 158 Shangtang Road, Hangzhou 310014,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangming","family":"Ye","sequence":"additional","affiliation":[{"name":"Center for Rehabilitation Medicine , Rehabilitation & Sports Medicine Research Institute of Zhejiang Province, Department of Rehabilitation Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, 158 Shangtang Road, Hangzhou 310014,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5721-2539","authenticated-orcid":false,"given":"Feng","family":"Liang","sequence":"additional","affiliation":[{"name":"Center for Rehabilitation Medicine , Rehabilitation & Sports Medicine Research Institute of Zhejiang Province, Department of Rehabilitation Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, 158 Shangtang Road, Hangzhou 310014,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"key":"2024102906051612800_ref1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1474-4422(03)00305-3","article-title":"Vascular cognitive impairment","volume":"2","author":"O'Brien","year":"2003","journal-title":"Lancet Neurol"},{"key":"2024102906051612800_ref2","doi-asserted-by":"crossref","first-page":"18003","DOI":"10.1038\/nrdp.2018.3","article-title":"Vascular cognitive impairment","volume":"4","author":"Flier","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"2024102906051612800_ref3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(08)70040-1","article-title":"Vascular cognitive impairment: current concepts and clinical developments","volume":"7","author":"Moorhouse","year":"2008","journal-title":"Lancet Neurol"},{"key":"2024102906051612800_ref4","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00401-016-1571-z","article-title":"Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer's disease","volume":"131","author":"Kalaria","year":"2016","journal-title":"Acta Neuropathol"},{"key":"2024102906051612800_ref5","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1161\/01.STR.0000248777.44128.93","article-title":"Beta-amyloid aggregation in human brains with cerebrovascular lesions","volume":"37","author":"Aho","year":"2006","journal-title":"Stroke"},{"key":"2024102906051612800_ref6","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1001\/jamaneurol.2022.3472","article-title":"Frequency and underlying pathology of pure vascular cognitive impairment","volume":"79","author":"Oveisgharan","year":"2022","journal-title":"JAMA Neurol"},{"key":"2024102906051612800_ref7","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1093\/brain\/aws271","article-title":"Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias","volume":"135","author":"Yarchoan","year":"2012","journal-title":"Brain"},{"key":"2024102906051612800_ref8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00401-005-1074-9","article-title":"Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms","volume":"110","author":"Attems","year":"2005","journal-title":"Acta Neuropathol"},{"key":"2024102906051612800_ref9","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/jnnp-2017-316851","article-title":"Amyloid-PET burden and regional distribution in cerebral amyloid angiopathy: a systematic review and meta-analysis of biomarker performance","volume":"89","author":"Charidimou","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2024102906051612800_ref10","first-page":"1","article-title":"Association of Blood Amyloid Beta-Protein 1-42 with Poststroke cognitive impairment: a systematic review and meta-analysis","volume":"2022","author":"Chen","year":"2022","journal-title":"Biomed Res Int"},{"key":"2024102906051612800_ref11","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMoa054625","article-title":"PET of brain amyloid and tau in mild cognitive impairment","volume":"355","author":"Small","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"2024102906051612800_ref12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1474-4422(08)70001-2","article-title":"Imaging of amyloid \u03b2 in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism","volume":"7","author":"Rowe","year":"2008","journal-title":"Lancet Neurol"},{"key":"2024102906051612800_ref13","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S1474-4422(11)70077-1","article-title":"Cerebral amyloid-\u03b2 PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study","volume":"10","author":"Barthel","year":"2011","journal-title":"Lancet Neurology [Article]"},{"key":"2024102906051612800_ref14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2010.2008","article-title":"Use of Florbetapir-PET for imaging \u03b2-amyloid pathology","volume":"305","author":"Clark","year":"2011","journal-title":"JAMA-Journal of the American Medical Association [Article]"},{"key":"2024102906051612800_ref15","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1161\/STROKEAHA.115.010449","article-title":"Influence of amyloid-beta on cognitive decline after stroke\/transient ischemic attack: three-year longitudinal study","volume":"46","author":"Liu","year":"2015","journal-title":"Stroke"},{"key":"2024102906051612800_ref16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12877-017-0522-4","article-title":"Associations between cerebral amyloid and changes in cognitive function and falls risk in subcortical ischemic vascular cognitive impairment","volume":"17","author":"Dao","year":"2017","journal-title":"BMC Geriatr"},{"key":"2024102906051612800_ref17","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1161\/STROKEAHA.116.013778","article-title":"Prevalence of amyloid positron emission tomographic positivity in Poststroke mild cognitive impairment","volume":"47","author":"Wollenweber","year":"2016","journal-title":"Stroke"},{"key":"2024102906051612800_ref18","doi-asserted-by":"crossref","first-page":"102553","DOI":"10.1016\/j.nicl.2020.102553","article-title":"Lack of association between acute stroke, post-stroke dementia, race, and beta-amyloid status","volume":"29","author":"Koenig","year":"2021","journal-title":"Neuroimage Clin"},{"key":"2024102906051612800_ref19","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"2024102906051612800_ref20","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1007\/s12975-021-00921-5","article-title":"Is cerebral amyloid-beta deposition related to post-stroke cognitive impairment?","volume":"12","author":"Ouyang","year":"2021","journal-title":"Transl Stroke Res"},{"key":"2024102906051612800_ref21","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1161\/01.STR.29.10.2196","article-title":"Beta-amyloid precursor protein and ss-amyloid peptide immunoreactivity in the rat brain after middle cerebral artery occlusion: effect of age","volume":"29","author":"Popa-Wagner","year":"1998","journal-title":"Stroke"},{"key":"2024102906051612800_ref22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nbd.2009.04.009","article-title":"Focal cerebral ischemia in rats alters APP processing and expression of Abeta peptide degrading enzymes in the thalamus","volume":"35","author":"Hiltunen","year":"2009","journal-title":"Neurobiol Dis"},{"key":"2024102906051612800_ref23","article-title":"Expression of amyloid precursor protein, Caveolin-1, alpha-, Beta-, and gamma-secretases in penumbra cells after Photothrombotic stroke and evaluation of neuroprotective effect of secretase and Caveolin-1 inhibitors","volume":"10","author":"Sharifulina","year":"2022","journal-title":"Biomedicine"},{"key":"2024102906051612800_ref24","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1161\/01.STR.0000169933.88903.cf","article-title":"Transformation of diffuse beta-amyloid precursor protein and beta-amyloid deposits to plaques in the thalamus after transient occlusion of the middle cerebral artery in rats","volume":"36","author":"Groen","year":"2005","journal-title":"Stroke"},{"key":"2024102906051612800_ref25","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1093\/brain\/awr300","article-title":"Cerebrovascular lesions induce transient beta-amyloid deposition","volume":"134","author":"Garcia-Alloza","year":"2011","journal-title":"Brain"},{"key":"2024102906051612800_ref26","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000334763","article-title":"Clearance of amyloid-beta protein deposits in transgenic mice following focal cerebral ischemia","volume":"10","author":"Van Nostrand","year":"2012","journal-title":"Neurodegener Dis"},{"key":"2024102906051612800_ref27","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1007\/s00259-023-06209-0","article-title":"Longitudinal head-to-head comparison of (11)C-PiB and (18)F-florbetapir PET in a phase 2\/3 clinical trial of anti-amyloid-beta monoclonal antibodies in dominantly inherited Alzheimer's disease","volume":"50","author":"Chen","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2024102906051612800_ref28","doi-asserted-by":"crossref","first-page":"e2850","DOI":"10.1002\/brb3.2850","article-title":"Amyloid-beta PET in Alzheimer's disease: a systematic review and Bayesian meta-analysis","volume":"13","author":"Ruan","year":"2023","journal-title":"Brain Behav"},{"key":"2024102906051612800_ref29","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1161\/STROKEAHA.116.014094","article-title":"Prestroke vascular pathology and the risk of recurrent stroke and Poststroke dementia","volume":"47","author":"Portegies","year":"2016","journal-title":"Stroke"},{"key":"2024102906051612800_ref30","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/STROKEAHA.116.015242","article-title":"Long-term risk of dementia among survivors of ischemic or Hemorrhagic stroke","volume":"48","author":"Corraini","year":"2017","journal-title":"Stroke"},{"key":"2024102906051612800_ref31","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1093\/brain\/aww214","article-title":"Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment","volume":"139","author":"Skrobot","year":"2016","journal-title":"Brain"},{"key":"2024102906051612800_ref32","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S1474-4422(16)30029-1","article-title":"Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study","volume":"15","author":"Arvanitakis","year":"2016","journal-title":"Lancet Neurol"},{"key":"2024102906051612800_ref33","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jns.2013.11.028","article-title":"Cerebrolysin reduces amyloid-beta deposits, apoptosis and autophagy in the thalamus and improves functional recovery after cortical infarction","volume":"337","author":"Xing","year":"2014","journal-title":"J Neurol Sci"},{"key":"2024102906051612800_ref34","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1161\/STROKEAHA.117.019439","article-title":"2-Cl-MGV-1 ameliorates apoptosis in the thalamus and hippocampus and cognitive deficits after cortical infarct in rats","volume":"48","author":"Chen","year":"2017","journal-title":"Stroke"},{"key":"2024102906051612800_ref35","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1177\/0271678X211005877","article-title":"More than motor impairment: a spatiotemporal analysis of cognitive impairment and associated neuropathological changes following cortical photothrombotic stroke","volume":"41","author":"Sanchez-Bezanilla","year":"2021","journal-title":"J Cereb Blood Flow Metab"},{"key":"2024102906051612800_ref36","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2017.09.007","article-title":"Progress toward standardised diagnosis of vascular cognitive impairment: guidelines from the vascular impairment of cognition classification consensus study","volume":"14","author":"Skrobot","year":"2018","journal-title":"Alzheimers Dement"},{"key":"2024102906051612800_ref37","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/gps.1209","article-title":"Neuropsychological characteristics of mild vascular cognitive impairment and dementia after stroke","volume":"19","author":"Stephens","year":"2004","journal-title":"Int J Geriatr Psychiatry"},{"key":"2024102906051612800_ref38","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.neuron.2015.02.027","article-title":"Common behavioral clusters and subcortical anatomy in stroke","volume":"85","author":"Corbetta","journal-title":"Neuron"},{"key":"2024102906051612800_ref39","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S1474-4422(18)30442-3","article-title":"Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford vascular study","volume":"18","author":"Pendlebury","year":"2019","journal-title":"Lancet Neurol"},{"key":"2024102906051612800_ref40","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S1474-4422(21)00060-0","article-title":"Strategic infarct locations for post-stroke cognitive impairment: a pooled analysis of individual patient data from 12 acute ischaemic stroke cohorts","volume":"20","author":"Weaver","year":"2021","journal-title":"Lancet Neurol"}],"container-title":["Age and Ageing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/53\/10\/afae240\/60183572\/afae240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/53\/10\/afae240\/60183572\/afae240.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T06:05:29Z","timestamp":1730181929000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ageing\/article\/doi\/10.1093\/ageing\/afae240\/7848490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ageing\/afae240","relation":{},"ISSN":["0002-0729","1468-2834"],"issn-type":[{"type":"print","value":"0002-0729"},{"type":"electronic","value":"1468-2834"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,10,1]]},"article-number":"afae240"}}